Data source

NH Nils Hohmuth
IK Ifrah Khanyaree
AL Anna-Lena Lang
OD Ohad Duering
SK Stefan Konigorski
VV Vukašin Višković
TH Tobias Heising
FE Friedemann Egender
CR Cornelius Remschmidt
RL Rasmus Leistner
ask Ask a question
Favorite

The data presented in this publication was collected using the study app infrastructure of a prospective cohort study which assessed the real-world effectiveness of COVID-19 vaccines (eCOV study, registered at Deutsches Register für Klinische Studien, ID: DRKS00025169). The study and the study app were developed by the not-for-profit organization Data4Life (Berlin, Germany). The study analyzing the MG was open for enrollment and reporting of data during the whole study period from 08/12/2021 to 10/31/2021. All data points reported after 10/31/2021 were not part of the MG study dataset, but participants could continue to report data to the eCOV study until 08/01/2022.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A